All Brands Owned by Cencora Inc.
Cencora Inc. owns 8 brands in our database. Browse the complete portfolio of Cencora Inc. subsidiaries and brands across various industries.
Company Type
public
Headquarters
Conshohocken, Pennsylvania, USA
Brand Portfolio
8 brands
Stock
NYSE: COR
Filter by Category
Complete Brand Portfolio
AmerisourceBergen
Owned by Cencora Inc.
American pharmaceutical distribution brand representing the legacy operations of Cencora Inc., formerly known as AmerisourceBergen Corporation, specializing in drug distribution services.
GoodRx
Owned by Cencora Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
Lash Group
Owned by Cencora Inc.
Patient support services company providing pharmaceutical patient assistance programs, enrollment services, and healthcare support owned by Cencora.
MWI Animal Health
Owned by Cencora Inc.
Animal health pharmaceutical and supply distributor providing veterinary medications, medical supplies, and technology solutions to veterinary clinics and animal healthcare providers owned by Cencora.
OneOncology
Owned by Cencora Inc.
Physician-led community oncology platform providing practice management, clinical support, and healthcare solutions to independent oncology practices owned by Cencora.
Retina Consultants of America
Owned by Cencora Inc.
Leading retina specialist management services organization providing practice management and clinical support to retina specialists and ophthalmology practices owned by Cencora.
World Courier
Owned by Cencora Inc.
Global specialty logistics and transportation company specializing in time-critical and temperature-sensitive pharmaceutical shipments for clinical trials and healthcare distribution.
Xcenda
Owned by Cencora Inc.
Strategic consulting and market access company providing commercialization support, market access strategy, and healthcare consulting services owned by Cencora.
About Cencora Inc.
What does Cencora do?
Cencora distributes pharmaceutical products, including brand-name drugs, generic drugs, and specialty medications, to pharmacies, hospitals, physician offices, and other healthcare providers across the United States and internationally. The company also provides manufacturer services, patient support programs, specialty logistics, and veterinary pharmaceutical distribution through its subsidiaries.
Is Cencora publicly traded?
Yes, Cencora, Inc. trades on the New York Stock Exchange under ticker symbol COR. The company has no controlling shareholder, though Walgreens Boots Alliance holds approximately 15% of shares as the largest single investor.
What is Cencora's annual revenue?
In fiscal year 2024 (ended September 30, 2024), Cencora reported revenue of $294.0 billion, a 12.1% increase from the prior fiscal year. The company is one of the largest companies in the United States by revenue.
Why did AmerisourceBergen change its name to Cencora?
AmerisourceBergen changed its name to Cencora in August 2023 to reflect its evolution from a primarily domestic pharmaceutical distributor into a global healthcare solutions organization. The rebranding followed the 2021 acquisition of Alliance Healthcare, which significantly expanded the company's international operations, and was intended to signal the company's broader capabilities beyond traditional drug distribution.
Who is Cencora's CEO?
Robert P. Mauch became President and CEO of Cencora on October 1, 2024, succeeding Steven H. Collis, who had served as CEO since 2011. Collis transitioned to the role of Executive Chairman.
What is Cencora's role in the opioid settlement?
Cencora, along with McKesson and Cardinal Health, reached a $21 billion settlement with U.S. states and local governments in 2022 to resolve claims that the three distributors failed to adequately monitor suspicious opioid orders. Cencora's share of the settlement is approximately $6.1 billion, to be paid over 18 years.
Stock Information
Competitors to Cencora Inc.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Cardinal Health | USA | 2010 | Mass Market | North America | All Genders | |
| Piramal Pharma | India | 2007 | Mass Market | Global | Male |
Learn More About Competitors
Cardinal Health Specialty Pharmacy
Owned by Cardinal Health
Specialty pharmaceutical distribution and services provider serving specialty pharmacies, hospitals, and healthcare providers with complex medications owned by Cardinal Health.
Piramal Pharma Solutions
Owned by Piramal Pharma Limited
Global contract development and manufacturing organization providing integrated CDMO services across the drug lifecycle for pharmaceutical companies.
Competitive Analysis
Market Positioning: Cencora Inc. competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Cencora Inc. Brand Portfolio Overview
Cencora Inc. maintains a diverse portfolio of 8 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
Brand Portfolio by Industry:
- Healthcare & Pharmaceuticals: 8 brands
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Cencora Inc.provides valuable insights into market dynamics, product relationships, and corporate strategy.
Explore More
Jobs at Cencora Inc.
Latest News About Cencora Inc.
Articles About Cencora Inc.
View more articles
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.
The Truth About 'Made in America' Brand Claims
Many brands market themselves as American-made. But what does that actually mean when the parent company is foreign, the parts come from overseas, and 'assembled in USA' is not the same as 'made in USA'?